Precision medicine is increasingly being adopted by U.S. health systems, with over three-quarters implementing formal programs for genetic testing and personalized care; however, challenges such as reimbursement, data integration, and patient engagement persist in scaling these initiatives. A report by UPMC indicates that while progress has been made, significant work remains to fully integrate genomics into clinical workflows and ensure broader reimbursement for precision medicine services.
The UPMC report highlights that while precision medicine is gaining traction in health systems, significant hurdles remain in scaling these programs, particularly around reimbursement, data integration, and patient engagement. For someone in healthtech, this signals an opportunity to develop solutions that enhance EHR interoperability, streamline genomic data management, and provide clear evidence of cost-effectiveness to alleviate payer concerns. Investing in infrastructure that supports seamless genomic data integration into clinical workflows could position a company as a critical enabler of precision medicine's broader adoption.